Bristol-Myers Squibb Co

Return on Assets, %

8.5

-2.7

Net income margin, %

15.3

2.8

EBITDA margin, %

44.2

10.8

Debt to Equity, %

135.1

19.2

Intangible assets and goodwill, %

50.6

3.6

Revenue CAGR 3Y, %

1.9

8.5

Total Equity change 1Y, %

-5.3

0

Revenue Y, % chg

-2.5

0.5

P/E

12.5

22.7

P/BV

3.3

1.5

P/S

2.1

2.3

EV/S

2.7

2.4

EV/EBITDA

6

7.4

Average Analyst recommendation

Hold

Hold

Average upside forecasts, %

13.9

51.3

Forward P/E

19.3

15.6

Dividend Yield, %

4.9

1.7

Forward Dividend Yield, %

5.1

0.2

Expected dividend per share

2.4

0

Payout Ratio, %

59.3

30.3

Dividend Ex Date

2024-04-04